We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
Cap. Flow
+$77.2M
Cap. Flow %
0.8%
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$53.4M
2
OXY icon
Occidental Petroleum
OXY
+$38M
3
COF icon
Capital One
COF
+$36.7M
4
ELV icon
Elevance Health
ELV
+$27.1M
5
KR icon
Kroger
KR
+$20.2M

Top Sells

Rank Stock Value
1
ALGN icon
Align Technology
ALGN
+$43.2M
2
MSFT icon
Microsoft
MSFT
+$36.6M
3
QCOM icon
Qualcomm
QCOM
+$34.8M
4
MA icon
Mastercard
MA
+$33.6M
5
MRK icon
Merck
MRK
+$33.4M

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Healthcare 14.84%
3 Consumer Discretionary 14.57%
4 Financials 13.21%
5 Industrials 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAKT icon
601
Daktronics
DAKT
$946M
$1.33M 0.01%
336,124
-18,495
-5% -$77.1K
PAGP icon
602
Plains GP Holdings
PAGP
$5.28B
$1.33M 0.01%
218,507
-13,503
-6% -$103K
BMRC icon
603
Bank of Marin Bancorp
BMRC
$460M
$1.33M 0.01%
45,932
-1,324
-3% -$41.6K
TRST
604
Trustco Bank Corp NY
TRST
$953M
$1.32M 0.01%
50,667
-9,586
-16% -$280K
VIRT icon
605
Virtu Financial
VIRT
$5.04B
$1.3M 0.01%
+56,667
New +$1.42M
ESPR
606
DELISTED
Esperion Therapeutics
ESPR
$1.3M 0.01%
34,952
-3,668
-9% -$145K
V icon
607
Visa
V
$677B
$1.29M 0.01%
6,469
-9,690
-60% -$1.94M
ANDE icon
608
Andersons Inc
ANDE
$2.39B
$1.28M 0.01%
+66,628
New +$1.1M
NKTR icon
609
Nektar Therapeutics
NKTR
$2.39B
$1.27M 0.01%
5,119
+1,217
+31% +$383K
MANH icon
610
Manhattan Associates
MANH
$11.9B
$1.27M 0.01%
13,320
+1,513
+13% +$143K
VEEV icon
611
Veeva Systems
VEEV
$33.8B
$1.27M 0.01%
4,506
+3,213
+248% +$847K
RYZ
612
Ryerson Holding Corp
RYZ
$1.49B
$1.26M 0.01%
220,176
+144
+0.1% +$836
BURL icon
613
Burlington
BURL
$23.4B
$1.26M 0.01%
6,098
– –
CC icon
614
Chemours
CC
$2.48B
$1.23M 0.01%
58,905
-119,971
-67% -$2.32M
THFF icon
615
First Financial Corp
THFF
$948M
$1.22M 0.01%
38,732
-3,662
-9% -$124K
CMRX
616
DELISTED
Chimerix, Inc.
CMRX
$1.21M 0.01%
487,388
-341
-0.1% -$1.01K
ACBI
617
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$1.21M 0.01%
106,903
-49,917
-32% -$556K
RUSHA icon
618
Rush Enterprises Class A
RUSHA
$6.34B
$1.2M 0.01%
+53,532
New +$1.14M
EGAN icon
619
eGain
EGAN
$186M
$1.2M 0.01%
84,555
-5,790
-6% -$67.5K
AVNW icon
620
Aviat Networks
AVNW
$253M
$1.19M 0.01%
108,284
+64,702
+148% +$666K
CTO
621
CTO Realty Growth
CTO
$839M
$1.19M 0.01%
99,302
-27,855
-22% -$311K
TISI icon
622
Team
TISI
$80.6M
$1.19M 0.01%
21,552
+17,207
+396% +$933K
GVA icon
623
Granite Construction
GVA
$5.16B
$1.18M 0.01%
67,044
-26,640
-28% -$487K
BYSI icon
624
BeyondSpring
BYSI
$47.3M
$1.18M 0.01%
88,663
+27,167
+44% +$353K
REV
625
DELISTED
Revlon, Inc.
REV
$1.18M 0.01%
186,553
+134,331
+257% +$1.03M
23 24
25
26 27

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q3 2020 Portfolio in Review

As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
  • Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
  • Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
  • Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
  • Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
  • Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
  • Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.